Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.577
-0.033 (-1.27%)
Nov 21, 2024, 1:33 PM EST - Market open
Vistagen Therapeutics Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 0.88 | 1.06 | -0.23 | 1.11 | 1.09 | - | Upgrade
|
| Revenue Growth (YoY) | 8.08% | - | - | 1.78% | - | - | Upgrade
|
| Gross Profit | 0.88 | 1.06 | -0.23 | 1.11 | 1.09 | - | Upgrade
|
| Selling, General & Admin | 16.64 | 14.06 | 14.66 | 13.96 | 7.64 | 7.96 | Upgrade
|
| Research & Development | 29.84 | 20.02 | 44.38 | 34.92 | 11.38 | 12.84 | Upgrade
|
| Operating Expenses | 46.48 | 34.09 | 59.04 | 48.89 | 19.02 | 20.8 | Upgrade
|
| Operating Income | -45.6 | -33.02 | -59.27 | -47.78 | -17.93 | -20.8 | Upgrade
|
| Interest Expense | - | - | - | - | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 5.73 | 3.35 | 0.03 | 0.02 | 0.02 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.31 | 0.31 | - | - | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -39.56 | -29.36 | -59.24 | -47.76 | -17.93 | -20.77 | Upgrade
|
| Pretax Income | -39.56 | -29.36 | -59.24 | -47.76 | -17.93 | -20.77 | Upgrade
|
| Income Tax Expense | 0.01 | 0 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Net Income | -39.57 | -29.36 | -59.25 | -47.76 | -17.93 | -20.77 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 0.95 | 24.39 | 1.26 | Upgrade
|
| Net Income to Common | -39.57 | -29.36 | -59.25 | -48.71 | -42.32 | -22.04 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 19 | 7 | 7 | 3 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 19 | 7 | 7 | 3 | 1 | Upgrade
|
| Shares Change (YoY) | 284.96% | 178.13% | 5.45% | 129.85% | 96.34% | 53.59% | Upgrade
|
| EPS (Basic) | -1.31 | -1.52 | -8.51 | -7.38 | -14.74 | -15.07 | Upgrade
|
| EPS (Diluted) | -1.31 | -1.52 | -8.51 | -7.38 | -14.74 | -15.07 | Upgrade
|
| Free Cash Flow | -33.65 | -25.87 | -49.93 | -45.46 | -12.35 | -15.76 | Upgrade
|
| Free Cash Flow Per Share | -1.11 | -1.34 | -7.17 | -6.89 | -4.30 | -10.78 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | 100.00% | 100.00% | - | Upgrade
|
| Operating Margin | -5205.59% | -3103.48% | - | -4308.68% | -1646.06% | - | Upgrade
|
| Profit Margin | -4516.55% | -2759.59% | - | -4392.42% | -3884.33% | - | Upgrade
|
| Free Cash Flow Margin | -3841.44% | -2431.77% | - | -4099.28% | -1133.45% | - | Upgrade
|
| EBITDA | -45.47 | -32.89 | -59.14 | -47.63 | -17.82 | -20.7 | Upgrade
|
| D&A For EBITDA | 0.14 | 0.13 | 0.13 | 0.15 | 0.12 | 0.1 | Upgrade
|
| EBIT | -45.6 | -33.02 | -59.27 | -47.78 | -17.93 | -20.8 | Upgrade
|
| Revenue as Reported | 0.88 | 1.06 | -0.23 | 1.11 | 1.09 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.